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Abstract
Computational models of the immune system (IS)
and pathogenic agents have several applications,
such as theory testing and validation, or as a com-
plement to first stages of drug trials. One possible
application is the prediction of the lethality of new
Influenza A strains, which are constantly created
due to antigenic drift and shift. Here, we present
several simulations of antigenic variability in In-
fluenza A using an agent-based approach, where
low level molecular antigen-antibody interactions
are explicitly described. Antigenic drift and shift
events are analyzed regarding the virulence of emer-
gent strains against the IS. Results are discussed
from a qualitative point of view taking into account
recent and generally recognized immunology and
influenza literature.
1 Introduction
There are several approaches to IS and pathogen
modeling [1], among which models based on dif-
ferential equations are probably the most common
[2]. This methodology is mostly used for modeling
particular aspects of the IS and pathogens, among
which is its use on the study of influenza dynamics
[3, 4, 5] and treatment [6].
Agent-based modeling (ABM) techniques are
well suited for describing the diversity of IS and
pathogen dynamics [7], taking into account behav-
ior distribution [8], simplified insertion of new enti-
ties or substances and natural consideration of non-
linear interactions between agents, capturing emer-
gent phenomena [9]. Most agent-based approaches
model a generic IS [10, 11, 12, 13, 14], and use such
model to simulate particular situations (e.g., HIV
infection [15, 16, 17], pulmonary tuberculosis [18])
or test specific theories (e.g. immunological mem-
ory [19]). Some models specifically target partic-
ular contexts; such is the case of the models de-
veloped by C. Beauchemin, used for the study of
influenza A infections. In [20], the influence of the
disease's spatial distribution is investigated using a
simple model capable of reproducing the virus ba-
sic dynamical features. The initial distribution of
infected cells, regeneration rate of dead cells and
proliferation rate of immune cells are further inves-
tigated in [21]. The same model was also used to
reproduce the dynamics of in vitro infection with
influenza A [22], effectively combining in vitro and
in silico tools.
In this study we describe an immune-influenza
A agent-based model, with emphasis on low level
molecular antigen-antibody interactions. The
model was developed using the LAIS simulator [23],
and can be divided in three parts: a) epithelium, a
tissue composed of epithelial cells, subject to infec-
tion by influenza A; b) IS cells, which work together
in order to remove infections; and c) influenza A
virions. Agents are modeled at the cellular (epithe-
lial and IS cells) or virion (influenza A) level. The
IS submodel has been successfully used in the sim-
ulation of bacterial attack and vaccine administra-
tion, demonstrating memory, specificity and spe-
cialization features [24]. In the present case, the
aim is to study antigenic drift and shift events in
influenza A, and analyze the virulence of emergent
strains. The main results of this study serve to
clarify: a) the fine balance of influenza antigens
in a successful infection; b) the role of specific IS
properties in dealing with influenza infection; c) the
difficulties antigenic drift can pose on the IS re-
sponse; and d) the potential dangers of antigenic
shift. Hopefully, this type of models could serve a
useful purpose in predicting the virulence of annual
influenza epidemics, and more importantly, the up-
rising of a lethal influenza pandemic due to anti-
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genic shift. In section 2 the influenza virus is pre-
sented from human and physiopathological points
of view. The LAIS simulator and the immune-
influenza A model are described in sections 3 and
4, respectively. In section 5 simulations and results
are presented and compared with immunology and
influenza theory from literature. Finally, in section
6 we conclude the presented work, underlining the
model's potential, envisaging possible forms of so-
lidifying the produced results.
2 The Influenza virus
Influenza is caused by a virus that attacks mainly
the upper respiratory tract, leading to symptoms
such as high fever, myalgia and sore throat, among
others. Most people recover without requiring any
medical treatment; however, in high-risk groups
(e.g. the elderly) the infection may lead to severe
complications of underlying diseases, pneumonia
and death. The disease spreads quickly at a global
level in seasonal epidemics, with significant eco-
nomic impact. Annual epidemics are estimated to
result in three to five million cases of severe illness
and between 250,000 and 500,000 deaths worldwide
[25].
Among the several types of influenza virus which
attack humans, type A has the highest mutation
rate and causes the most aggressive symptoms, be-
ing responsible for all known influenza pandemics
[26, 27, 25].
2.1 Physiopathology
Influenza, as most viruses, takes over the replica-
tive machinery of host cells in order to grow and re-
produce, with cunning strategies to evade immune
defenses. More specifically, influenza virus infects
epithelial cells of the respiratory tract.
Cytotoxic T cells (Tc) are crucial in the elimi-
nation of viral infection, killing infected cells via
recognition of a complex formed by viral antigenic
peptide and MHC class I self molecules [28, 29].
The release of IFN-γ by Helper T cells (Th) is an-
other important aspect of the immune response,
promoting resistance to viral subversion. Usually,
in a primary viral encounter, the defensive role of
antibody is diminished, as viral particles take shel-
ter in the intracellular habitat, mostly infecting ad-
jacent cells, thus limiting their extracellular expo-
sure. When an antibody response is initiated, the
infection is either widespread or controlled by cell-
mediated mechanisms. However, antibody plays an
important part in preventing reinfection: in sec-
ondary challenges specific memory B cells exist and
are ready to produce high affinity antibodies which
will bind and neutralize free virions before they gain
entrance into host cells.
One of the strategies the influenza virus uses to
escape detection is changing antigens by drift or
shift. In the first case, drift occurs through point
mutations in the viral genome during replication,
which can lead to a loss of immunity from previ-
ously existing antibodies. Major antigen changes
take place during antigenic shift, which can oc-
cur when two viruses simultaneously infect a host
cell; the infected cell acts as a mixing vessel, pro-
ducing a new virus composed of genome segments
belonging to the original viruses [30]. Influenza
A displays both these strategies; antigenic drift
causes seasonal influenza epidemics, while antigen
shift, although rarer, may cause serious influenza
pandemics [26]. Influenza A carries two surface
antigens, hemagglutinin (HA) and neuraminidase
(NA), both of which recognize the same host re-
ceptor, sialic acid [31]. HA and NA define the
virus subtype accordingly to their reactivity [30].
Some well know subtypes, due to their lethality, are
H1N1 (Spanish flu, 1918), H2N2 (Asian flu, 1957),
H3N2 (Hong Kong Flu, 1968) and H5N1 (avian flu,
current pandemic threat) [26, 27]. HA binds sialic
acid, a necessary first step for gaining entry into
the host cell; NA on the other hand cleaves sialic
acid to facilitate the release of progeny virus and
promote the spread of infection. A successful infec-
tion depends, among other factors, on the balance
of these two antigens [31].
3 LAIS simulator
The LAIS simulator is a multithreaded agent-based
simulation platform, offering a set of tools for the
simulation of biological systems. The platform is
implemented in Java and makes use of following
open source libraries: a) the Repast Agent Sim-
ulation Toolkit [32] classes that provide or sim-
plify spatial organization and visualization, event
scheduling and simulation output (e.g., charts,
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CSV files, movies); and b) the Simple XML seri-
alization library1 that provides simple class devel-
opment and instantiation using XML.
The two main actors in the LAIS framework are
substances and agents. The simulator is organized
in two layers: a) a specialized cellular automaton
(CA) responsible for substance diffusion, reaction
and degradation; and, b) the agent layer where the
agents move and act. The communication between
these layers occurs when agents produce or con-
sume substances, or when an agent action depends
on the underlying substances. Current implemen-
tation restricts the simulation to discrete time and
two-dimensional space. The multithreading capa-
bilities of the simulator work by equally distribut-
ing the CA cells through a number of threads de-
pendent on the number of available processor cores;
this is possible because during a simulation step,
each CA cell becomes an independent processing
unit [23].
3.1 Substances
Substances are uniquely identified by a 64 bit
string, allowing a repertoire of 264 ≈ 1019 differ-
ent substances. In the model specification it is
possible to attribute specific biological functions
to different bit substrings. The biological affinity
between substances primarily depends on the exis-
tence of complementary zones, i.e., regions where
the biological substances can fit with each other.
To mimic the IS, the bit string of substances that
model IS antibodies are composed by: a) a constant
region responsible for secondary functions such as
macrophage binding or complement fixation, and
b) a variable region which is used to determine the
binding affinity with antigen. The biological affin-
ity is implemented by the Hamming distance be-
tween two substance bitstrings [33].
LAIS represents substances as real valued con-
centrations, allowing to: a) model diffusion and re-
action phenomena in the CA layer; and b) simu-
late the substances present on the agent surface,
in the agent layer. Antigens are modeled as sub-
stances and thus differentiated from pathogenic
agents themselves.
New substances can be dynamically created dur-
ing simulation as the result of: a) different sub-
1http://simple.sourceforge.net/
stances produced by mutation of cloning agents;
and, b) substance merging. Merging can be either
affinity dependent, such as in the antigen-antibody
complex formation or independent, such as in the
case of the complex formed by MHC and the anti-
gen peptide.
The simulator offers the possibility to group the
substances into families in order to: a) simplify the
process of tracking substances with similar func-
tions, e.g. in B cell response, where a multitude
of different antibodies are temporarily produced;
and, b) allow the definition of substance merging
rules affecting specific families. In the latter case,
model specification is considerably facilitated and
the substance merging simulation becomes compu-
tationally feasible.
3.2 Agents
Agents have a set of conditional rules which eval-
uate state, superficial substance concentration and
the local CA cell, analyzing local substance concen-
tration, as well as substances displayed by other
agents. These rules are grouped in lists of rules;
each list of rules is associated to a list of actions. A
rule list - action list mapping is called a gene. In
order to perform the actions in a list, all the rules
in the associated gene rule list must yield true. Fig.
1 shows the schematics of a LAIS agent. Rules and
actions are hard-coded Java classes, but accept in-
stantiation parameters, making them flexible. The
grouping of rules and actions with different instan-
tiation parameters permits a vast range of behav-
iors. If a particular behavior cannot be achieved
using available rules and actions, it is relatively
simple to code additional ones, following specific
interfaces. The agent set of genes (each one being
a rule list - action list mapping) can be referred as
the agent's genotype. Evolution takes place when
an agent creates another agent, either by a cloning
process (e.g., cellular division) or by producing a
different type of agent (e.g., an infected immune
cell producing viruses). In such cases, rules and
actions are also cloned. These have a mutation pa-
rameter which can modify referenced substances.
Agent movement is controlled by these rules; move-
ment can be random, inertial (higher probability of
moving forward) or substance dependent (simulat-
ing chemotaxis, cell movement directed by a chemi-
cal concentration gradient [28]). LAIS supports the
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Figure 1  The LAIS agent model.
exchange of genetic code (at gene level) [16], allow-
ing models to represent realistic evolving systems.
4 Model description
One of the most complex challenges when develop-
ing a IS model is to find a balance between scale,
granularity and computational feasibility. Features
that are included in the model should not only be
theoretically and experimentally sound, but also
relevant for in the context of the simulations to
perform. Knowledge gaps, incomplete data and
excluded system features imply that models are in-
complete, always abstract to some point. However,
an incomplete model can still do a good job of sim-
ulating reality. Biological systems can also work
without various parts; they are robust, having re-
dundant features and components with overlapping
functions. As such, if a model captures the prin-
cipal components of a biological system, there is
no reason why it cannot yield realistic simulations
[34].
The model here presented includes several dis-
tinct entities and substances which approximately
reflect aspects we consider the most relevant of
immune-influenza A dynamics. Tables 1 and 2 re-
spectively summarize characteristics of agents and
substances included in the model.
5 Simulations and results
The simulations presented in this section were per-
formed using a 14x14 toroidal hexagonal grid. Dur-
ing a steady-state phase, were no infection or IS
response is taking place, the number of distinct
agents varies between 400 and 500. At peak im-
mune responses, the number of distinct agents can
reach 2× 105.
These simulations yielded a considerable quan-
tity of data, of which we present and interpret the
most relevant, either in the form of graphs or tex-
tual descriptions during analysis and discussion of
simulations.
5.1 Influenza subtypes and antigenic
drift
The balance of sialic acid affinity between HA and
NA antigens is of major importance for efficient
virus replication [31]. In this experiment, four sim-
ulations are performed, each with the deployment
of one influenza subtype at ticks 50 and 500. Each
subtype has a different set of superficial antigens,
with specific affinities for sialic acid (the superfi-
cial receptor of epithelial cells). Table 3 shows the
different antigens bit string and affinity with sialic
acid (whose bit string is 04D2h), prior to muta-
tion; only the 16 less significant bits are relevant
for this affinity; bits 16 to 31 (in italic) are used to
determine affinity with TCR when antigen is com-
plexed with MHC. These affinity values are merely
demonstrative, and do not correlate with sialic acid
affinity of real HA and NA types.
The four antigens presented in table 3 allow to
experiment with four influenza subtypes: H1N1,
H1N2, H2N1 and H2N2. Again, these do not cor-
relate with the real subtypes.
5.1.1 Analysis of results
The H1N1 subtype has high affinity HA and NA,
meaning it can rapidly infect cells (due to HA), and
proliferate in larger quantities (due to NA). In prin-
ciple, this should be the most lethal strain. How-
ever, that is not the case. Its rapid proliferation,
killing and infecting epithelial cells too fast (fig. 2),
limits its own expansion; the sudden high number
of extracellular virions draws the attention of hu-
moral mechanisms; the presence of a large number
of locally infected cells provokes a strong Th cell
reaction, due to B cell and APC antigen presenta-
tion; this leads to the production of IFN-γ (limiting
the spread of the infection) and the activation of Tc
cells ; these destroy locally infected epithelial cells,
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Table 1  Agents included in immune-influenza A model.
Agent Type Behavior
Influenza A Pathogen (virus) Infect and insert genetic code in epithelial cells, forcing them to produce
influenza A virions; infection is dependent on HA antigen-sialic acid affin-
ity, while virion release is dependent on NA antigen-sialic acid affinity.
Epithelial cell Epithelium Non-moving agents; display sialic acid at surface.
Tc cell Immune System Kill infected cells (i.e., cells displaying MHC Class I + antigenic peptide
complex).
Th cell Immune System Produce substances which assist other immune cells.
B cell Immune System Produce antibody; present antigen to Th cells via MHC Class II.
APC cell Immune System Phagocyte (ingest) pathogenic agents and antigens, with greater proba-
bility if pathogen is covered with antibody (opsonized); present antigen
to Th cells via MHC Class II.
putting a definitive stop to the viral infection. In its
first strike, the H1N1 strain lasted approximately
215 ticks, with a maximum of 80 simultaneous ep-
ithelial infections (fig. 2).
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Figure 2  Healthy and infected epithelial cells
during challenge from H1N1 subtype.
The H1N2 and H2N1 strains proved to be more
infectious, lasting about 275 ticks in their first
strike (figs. 3 and 4, respectively). H1N2 can infect
cells quickly (high affinity HA), but the number of
released virions is low (low affinity NA), resulting
in a maximum of less than 20 virions simultane-
ously present in the extracellular milieu; however,
a maximum of 80 simultaneous epithelial infections
indicates this is not an handicap, on the contrary,
the low virus titer allows it to remain concealed
from humoral mechanisms, with barely detectable
Th and B cell responses. As a consequence, lit-
tle humoral memory was created. In the second
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Figure 3  Healthy and infected epithelial cells
during challenge from H1N2 subtype.
strike, the strain provokes a state of chronic ill-
ness lasting a record value of 390 ticks, the highest
value of all eight infections (four primary, four sec-
ondary), with virus titer never reaching the 30 unit
mark. On the other hand, the maximum viral titer
in the primary H2N1 infection is of 46 units (the
highest of all eight infections), but correspondently
provokes the most powerful humoral response (figs.
8); the immune memory created quickly eliminated
the strain during the second strike, lasting no more
than 130 ticks.
The H2N2 strain, with low affinity HA and NA,
proved to be the least resistant and the least infec-
tious (fig. 5).
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Table 2  Substances included in immune-influenza A model.
Substance Source Location Effector function
Interferon-γ, IFN-γ Th Local Inhibits sialic acid production in epithelial cells,
protecting them from infection; increases proba-
bility of epithelial cell apoptosis.
Interleukin-2, IL-2 Th Local Induces proliferation of activated Th, Tc and B
cells.
Interleukin-12, IL-12 APC Local Induces Th proliferation and IFN-γ production.
Antibodies (family) B Local, Superficial Variable region binds antigen depending on affin-
ity; constant region (Fc) binds Fc receptors on
APC cells.
Antigens (family) Influenza A Local, Superficial HA antigens bind sialic acid promoting infection,
NA antigens cleave sialic acid promoting virion re-
lease.
MHC Class I Epithetial cells Superficial When complexed with antigenic peptide, can bind
TCR CD8 in Tc cells, depending on affinity.
MHC Class II APC, B Superficial When complexed with antigenic peptide, can bind
TCR CD4 in Th cells, depending on affinity.
TCR CD8 Tc Superficial Binds MHC Class I + antigenic peptide complex
present on the surface of infected epithelial cells,
promoting the destruction of such cells.
TCR CD4 Th Superficial Binds MHC Class II + antigenic peptide complex
present on the surface of APCs and B cells, pro-
moting assistance to such cells.
Fc receptor APC Superficial Binds antibody constant region, promoting more
efficient phagocytosis.
Sialic acid Epithetial cells Superficial Recognized by HA and NA influenza antigens.
Table 3  Influenza antigens bit string and affinity
with sialic acid.
Antigen Bit string Affinity
HA1 0707 7B21h 0.8125
HA2 1616 0622h 0.3125
NA1 2D2D 1B2Dh 0.8125
NA2 3C3C 0BDDh 0.5000
5.1.2 Balance between HA and NA anti-
gens
This experiment demonstrated the fine balance be-
tween HA and NA antigens and their importance in
a successful infection. A high affinity HA antigen
seems to be more important for kick starting the
infection, while NA functions like a throttle, deter-
mining the number of released virions. As observed
in the simulations, high affinity NA is probably not
an optimum companion for high affinity HA. More
testing is required in order to better explore HA-
NA balance, and its exact effect on the success of an
infection. Such a study must take into account that
influenza strains may have other infectivity param-
eters, and that antigenic drift causes noise which
can difficult the analysis of results. In this last
case, the solution is to perform a greater number
of tests for the same parameters, in order to obtain
more statistically significant results.
5.1.3 Effects of antigenic drift in immune
response, immune memory and anti-
body effectiveness
Antigenic drift can be asserted indirectly by con-
sidering the number of different antigens present
in the simulation environment. The IS tries to re-
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Figure 4  Healthy and infected epithelial cells
during challenge from H2N1 subtype.
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Figure 5  Healthy and infected epithelial cells
during challenge from H2N2 subtype.
spond with the production of a larger diversity of
antibody, in a reaction to the stimulus from the
many different antigens.
In all cases, except for H1N2, immune memory
was acquired against the invading strain. How-
ever, the effectiveness of memory is reduced when
compared to a simulation of non-mutating bacte-
ria using the same simulation platform and basic
IS model [24]; in this case, it was possible to ob-
serve a relatively high degree of antigen-antibody
complex; this occurs because B cells are stimulated
by a single antigen, resulting in plasma cells which
produce high affinity antibody; this antibody binds
large quantities of antigen, resulting in also large
quantities of antigen-antibody complex. In the case
presented here, figs. 6, 7, 8 and 9 show that very
small quantities of antigen-antibody complex are
produced. This happens due to antigenic drift; each
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Figure 6  Substance family concentration during
challenge from H1N1 subtype.
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Figure 7  Substance family concentration during
challenge from H1N2 subtype.
newly created influenza virion can be different from
its precursor, deploying different types of antigen,
not yet known to the latest versions of antibody
[29].
5.1.4 Role of Tc cells
As described in literature, the average number of
Tc cells during an immune response is one order
of magnitude above the number of Th cells [28],
which was confirmed by the obtained results. Sud-
den drops in infected epithelial numbers, visible in
figs. 2, 3, 4 and 5, occur practically at the same
time when effector Tc cells begin to be massively
produced, thus demonstrating their cytotoxic func-
tion.
7
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.2
30
3.
1 
: P
os
te
d 
15
 S
ep
 2
00
8
0 100 200 300 400 500 600 700 800 900 1000
0
500
1000
1500
2000
2500
Ticks
Co
nc
en
tra
tio
n
 
 
Antigens
Antibodies
Antigen+
Antibody
Complex
Figure 8  Substance family concentration during
challenge from H2N1 subtype.
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Figure 9  Substance family concentration during
challenge from H2N2 subtype.
5.2 Antigenic shift
Antigenic shift is a major antigenic change which
occurs at irregular intervals, being the main respon-
sible for influenza pandemics. In the influenza virus
family, only influenza A is susceptible to this event.
Antigenic shift can lead to the evolution of new hu-
man influenza A virus through the acquisition of a
new HA gene encoding a different subtype from an
avian influenza, or by the adaptation of an avian
virus, causing it to become transmissible between
humans [26].
In this experiment we infect the host with two
different influenza strains, H1N2 and H2N1, which
were studied separately in the previous subsection.
The goal is to verify the occurrence of antigenic
shift, and if it leads to the creation of a more infec-
tious subtype.
At tick 50, 25 units of H1N2 and 25 units of H2N1
are deployed in the simulation environment. Con-
trary to what was verified in the previous subsec-
tion, H2N1 seems to adapt better in a competitive
situation; as can be verified in fig. 10, H2N1 virion
titer is constantly superior to that of H1N2.
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Figure 10  Evolution of Influenza A subtypes
during antigenic shift simulation.
The appearance of H1N1 subtype confirms the
existence of antigenic shift; at tick 175, the emer-
gent H1N1 subtype experiences a fast rise, surpass-
ing the impact of the H1N2 subtype, which never
really takes off, as opposed to what was observed
in the previous experience. However, the emer-
gent H1N1 subtype does not become more infec-
tious than the original H1N2, which becomes the
IS main adversary. The overall infection was elim-
inated in 250 ticks, slightly faster than what was
verified in some of the previous cases. The higher
number of initially inserted virions would suggest
that this combination is weaker than the insertion
of isolated strains; however, the elevated number
of viral titter may also have conducted to a faster
humoral response, accelerating the removal of in-
fection; this is corroborated by fig. 12, which in-
dicates a 100 tick interval between virion insertion
and beginning of humoral response; in the previ-
ous cases this value was closer to 150 ticks (figs. 6
and 8). The H2N1 original strain reached a maxi-
mum value of 65 units of circulating virion, fig. 10,
higher than any of the previous cases. From ticks
150 to 190, there were more infected epithelial cells
than healthy ones (fig. 11), a situation which never
occurred while the subtypes were studied in isola-
tion.
When the B cell response takes place, cells under-
going somatic hypermutation do not often become
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Figure 11  Evolution of epithelial cells during
antigenic shift simulation.
plasma cells; in fact, plasma cell number barely
surpasses half the number of cells in somatic hy-
permutation, confirming the difficulty in keeping
pace with continuously mutating and recombining
antigens. This is further verified in fig. 12, show-
ing elevated antigen diversity (the highest in all in-
fluenza simulations). Production of antigen + anti-
body complex was very low, in spite of the variety
of produced antibodies.
Several Tc cells become activated at tick 75 due
to recognition of MHC Class I + antigen complex
presented by epithelial cells; however, they lack
the ability of becoming effector without the help
of Th cells, which only occurs from tick 150 on-
ward, when the humoral response takes place. At
this stage, IFN-γ kicks in, slowing the spread of
infection; a few effector Tc cells also begin to elimi-
nate infected epithelials. At tick 200, a spike in Tc
clonal expansion and effector production results in
the rapid extermination of infected cells (fig. 11);
when the remaining virion infect healthy cells, the
massive quantity of Tc effector clones immediately
eliminates such cells, severely limiting the replica-
tion capabilities of the virus. After the infection is
fully removed and IFN-γ dissipated, epithelial cells
begin to populate epithelial free spaces.
6 Conclusions
Simulation results were within our initial expec-
tations. A novel simulation of immune-influenza
A infections was developed and successfully tested
against theoretical data from literature. The anti-
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Figure 12  Substance family diversity during
antigenic shift simulation.
genic drift simulations demonstrated the impor-
tance of HA and NA balance in a successful infec-
tion, while clarifying the role of specific IS cells in
the immune response; the difficulties antigenic drift
can pose on the IS response were also asserted. In
the antigenic shift experiment, though the event
was observed, the appearance of a lethal strain was
not verified. To further study this event, more sub-
types should be taken into account and other infec-
tivity parameters, such as virion extracellular sur-
vival time, should be considered.
Given the stochastic nature of these simulations
and considering the complexity of simultaneous
antigenic drift and shift, each set of parameters
should be tested a sufficient number of times in
order to be adequately explored from a statistical
point of view. Nonetheless, the achieved results
demonstrate that this model could be a starting
point for predicting the impact of influenza epi-
demics and the probability of pandemic outbreak.
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